Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q3 2022 Earnings
ALNY
28
Jul
Confirmed
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-2.29
-2.02
-1.75
-1.48
Details
Expected EPS
-1.63
Actual EPS
-2.29
Surprise EPS
-0.66
Surprise Percent
+40.49%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.29 per share for Q3 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login